Global Veterinary Therapeutics Market to Hit USD 72,379.12 Million, Globally By 2030 at 7.20% CAGR | Infinium Global Research

Infinium Global Research, a leading market research firm, has released an extensive report dissecting the dynamics of the Global Veterinary Therapeutics Market. The report provides an in-depth analysis of segments and sub-segments within the global and regional veterinary therapeutics markets, elucidating the impactful drivers, restraints, and macro indicators shaping both short-term and long-term market trends.

The comprehensive study presents an all-encompassing view of trends, forecasts, and monetary values, offering a compelling overview of the burgeoning global veterinary therapeutics market.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/360

Market Insight:

The global veterinary therapeutics market, valued at USD 42,128.39 million in 2022, is projected to surge to USD 72,379.12 million by 2030, marking a notable Compound Annual Growth Rate (CAGR) of 7.20% during the forecast period from 2023 to 2030.

Veterinary therapeutics encompass a spectrum of applications, from diagnosing animal diseases to preventing and treating infections or injuries. This vital branch of animal healthcare involves drugs for disease treatment, vaccines for prevention, and overall health maintenance of animals. Diverse vaccines such as inactivated, live attenuated, recombinant vaccines, among others, play pivotal roles in addressing veterinary disorders and ensuring the well-being of animals.

The burgeoning market growth is attributed to the escalating prevalence of diseases among animals, driving the demand for veterinary drugs essential in combating various illnesses. Moreover, the surge in pet ownership, influenced by changing family structures and the increasing need for companionship, directly contributes to the thriving veterinary therapeutics market. Additionally, the introduction and advancement of new drugs stand as significant drivers for global market growth.

Challenges persist in the form of limited public awareness regarding animal health, hindering market expansion. However, the increasing focus on research and development within the veterinary therapeutics arena for more effective drug development presents lucrative opportunities for market growth.

Regional Insights:

The market segmentation spans North America, Europe, Asia Pacific, and the rest of the world. North America is poised to dominate the veterinary therapeutics market, boasting an advanced and well-equipped animal healthcare infrastructure. The region's highly educated populace, coupled with increased awareness of animal health significance, fuels market growth. Additionally, Europe, notably supported by countries like the UK and Germany, plays a pivotal role in revenue generation, driven by the availability of cost-effective drugs and the adoption of advanced veterinary therapeutics.

Segmentation and Key Players:

The report segments the veterinary therapeutics market based on product type, animal type, and route of administration. Key sub-markets include drugs, vaccines, medicated feed additives, companion animals, livestock animals, and various administration routes like oral, parenteral, and topical.

Companies profiled in the report comprise Boehringer Ingelheim, Bayer AG, Dechra Pharmaceuticals, Ceva Santé Animale, Elanco, Merck Animal Health, Virbac, Merial (acquired by Boehringer Ingelheim), Zoetis Services LLC, and Vetoquinol.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/360

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Veterinary Therapeutics Market Highlights

2.2. Veterinary Therapeutics Market Projection

2.3. Veterinary Therapeutics Market Regional Highlights

Chapter 3. Global Veterinary Therapeutics Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter`s Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Product Type

3.4.2. IGR-Growth Matrix Analysis by Animal Type

3.4.3. IGR-Growth Matrix Analysis by Route of Administration

3.4.4. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Veterinary Therapeutics Market

Chapter 4. Veterinary Therapeutics Market Macro Indicator Analysis

Chapter 5. Company Profiles and Competitive Landscape

5.1. Competitive Landscape in the Global Veterinary Therapeutics Market

5.2. Companies Profiles

5.2.1. Boehringer Ingelheim

5.2.2. Bayer AG

5.2.3. Dechra Pharmaceuticals

5.2.4. Ceva Santé Animale

5.2.5. Elanco

5.2.6. Merck Animal Health

5.2.7. Virbac

5.2.8. Merial (acquired by Boehringer Ingelheim)

5.2.9. Zoetis Services LLC

5.2.10. Vetoquinol

Chapter 6. Global Veterinary Therapeutics Market by Product Type

6.1. Drugs

6.2. Vaccines

6.3. Medicated Feed Additives

Chapter 7. Global Veterinary Therapeutics Market by Animal Type

7.1. Companion Animal

7.2. Livestock Animal

Chapter 8. Global Veterinary Therapeutics Market by Route of Administration

8.1. Oral

8.2. Parenteral

8.3. Topical

Chapter 9. Global Veterinary Therapeutics Market by Region 2023-2030

9.1. North America

9.1.1. North America Veterinary Therapeutics Market by Product Type

9.1.2. North America Veterinary Therapeutics Market by Animal Type

9.1.3. North America Veterinary Therapeutics Market by Route of Administration

9.1.4. North America Veterinary Therapeutics Market by Country

9.1.4.1. The U.S. Veterinary Therapeutics Market

9.1.4.1.1. The U.S. Veterinary Therapeutics Market by Product Type

9.1.4.1.2. The U.S. Veterinary Therapeutics Market by Animal Type

9.1.4.1.3. The U.S. Veterinary Therapeutics Market by Route of Administration

9.1.4.2. Canada Veterinary Therapeutics Market

9.1.4.2.1. Canada Veterinary Therapeutics Market by Product Type

9.1.4.2.2. Canada Veterinary Therapeutics Market by Animal Type

9.1.4.2.3. Canada Veterinary Therapeutics Market by Route of Administration

9.1.4.3. Mexico Veterinary Therapeutics Market

9.1.4.3.1. Mexico Veterinary Therapeutics Market by Product Type

9.1.4.3.2. Mexico Veterinary Therapeutics Market by Animal Type

9.1.4.3.3. Mexico Veterinary Therapeutics Market by Route of Administration

9.2. Europe

9.2.1. Europe Veterinary Therapeutics Market by Product Type

9.2.2. Europe Veterinary Therapeutics Market by Animal Type

9.2.3. Europe Veterinary Therapeutics Market by Route of Administration

9.2.4. Europe Veterinary Therapeutics Market by Country

9.2.4.1. Germany Veterinary Therapeutics Market

9.2.4.1.1. Germany Veterinary Therapeutics Market by Product Type

9.2.4.1.2. Germany Veterinary Therapeutics Market by Animal Type

9.2.4.1.3. Germany Veterinary Therapeutics Market by Route of Administration

9.2.4.2. United Kingdom Veterinary Therapeutics Market

9.2.4.2.1. United Kingdom Veterinary Therapeutics Market by Product Type

9.2.4.2.2. United Kingdom Veterinary Therapeutics Market by Animal Type

9.2.4.2.3. United Kingdom Veterinary Therapeutics Market by Route of Administration

9.2.4.3. France Veterinary Therapeutics Market

9.2.4.3.1. France Veterinary Therapeutics Market by Product Type

9.2.4.3.2. France Veterinary Therapeutics Market by Animal Type

9.2.4.3.3. France Veterinary Therapeutics Market by Route of Administration

9.2.4.4. Italy Veterinary Therapeutics Market

9.2.4.4.1. Italy Veterinary Therapeutics Market by Product Type

9.2.4.4.2. Italy Veterinary Therapeutics Market by Animal Type

9.2.4.4.3. Italy Veterinary Therapeutics Market by Route of Administration

9.2.4.5. Rest of Europe Veterinary Therapeutics Market

9.2.4.5.1. Rest of Europe Veterinary Therapeutics Market by Product Type

9.2.4.5.2. Rest of Europe Veterinary Therapeutics Market by Animal Type

9.2.4.5.3. Rest of Europe Veterinary Therapeutics Market by Route of Administration

9.3. Asia Pacific

9.3.1. Asia Pacific Veterinary Therapeutics Market by Product Type

9.3.2. Asia Pacific Veterinary Therapeutics Market by Animal Type

9.3.3. Asia Pacific Veterinary Therapeutics Market by Route of Administration

9.3.4. Asia Pacific Veterinary Therapeutics Market by Country

9.3.4.1. China Veterinary Therapeutics Market

9.3.4.1.1. China Veterinary Therapeutics Market by Product Type

9.3.4.1.2. China Veterinary Therapeutics Market by Animal Type

9.3.4.1.3. China Veterinary Therapeutics Market by Route of Administration

9.3.4.2. Japan Veterinary Therapeutics Market

9.3.4.2.1. Japan Veterinary Therapeutics Market by Product Type

9.3.4.2.2. Japan Veterinary Therapeutics Market by Animal Type

9.3.4.2.3. Japan Veterinary Therapeutics Market by Route of Administration

9.3.4.3. India Veterinary Therapeutics Market

9.3.4.3.1. India Veterinary Therapeutics Market by Product Type

9.3.4.3.2. India Veterinary Therapeutics Market by Animal Type

9.3.4.3.3. India Veterinary Therapeutics Market by Route of Administration

9.3.4.4. South Korea Veterinary Therapeutics Market

9.3.4.4.1. South Korea Veterinary Therapeutics Market by Product Type

9.3.4.4.2. South Korea Veterinary Therapeutics Market by Animal Type

9.3.4.4.3. South Korea Veterinary Therapeutics Market by Route of Administration

9.3.4.5. Australia Veterinary Therapeutics Market

9.3.4.5.1. Australia Veterinary Therapeutics Market by Product Type

9.3.4.5.2. Australia Veterinary Therapeutics Market by Animal Type

9.3.4.5.3. Australia Veterinary Therapeutics Market by Route of Administration

9.3.4.6. Rest of Asia-Pacific Veterinary Therapeutics Market

9.3.4.6.1. Rest of Asia-Pacific Veterinary Therapeutics Market by Product Type

9.3.4.6.2. Rest of Asia-Pacific Veterinary Therapeutics Market by Animal Type

9.3.4.6.3. Rest of Asia-Pacific Veterinary Therapeutics Market by Route of Administration

9.4. RoW

9.4.1. RoW Veterinary Therapeutics Market by Product Type

9.4.2. RoW Veterinary Therapeutics Market by Animal Type

9.4.3. RoW Veterinary Therapeutics Market by Route of Administration

9.4.4. RoW Veterinary Therapeutics Market by Sub-region

9.4.4.1. Latin America Veterinary Therapeutics Market

9.4.4.1.1. Latin America Veterinary Therapeutics Market by Product Type

9.4.4.1.2. Latin America Veterinary Therapeutics Market by Animal Type

9.4.4.1.3. Latin America Veterinary Therapeutics Market by Route of Administration

9.4.4.2. Middle East Veterinary Therapeutics Market

9.4.4.2.1. Middle East Veterinary Therapeutics Market by Product Type

9.4.4.2.2. Middle East Veterinary Therapeutics Market by Animal Type

9.4.4.2.3. Middle East Veterinary Therapeutics Market by Route of Administration

9.4.4.3. Africa Veterinary Therapeutics Market

9.4.4.3.1. Africa Veterinary Therapeutics Market by Product Type

9.4.4.3.2. Africa Veterinary Therapeutics Market by Animal Type

9.4.4.3.3. Africa Veterinary Therapeutics Market by Route of Administration

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/360

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of Veterinary Therapeutics.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.